Financial toxicity and its implication on quality of life in patients attending the palliative care department in a regional cancer centre: An observational study.

Autor: Nikte V; Department of Pharmacy Practice, R. C. Patel Institute of Pharmaceutical Education and Research, Shirpur, 425405 Dhule, Maharashtra, India. Electronic address: vaishnavinikte44@gmail.com., Patil S; Department of Pharmacy Practice, R. C. Patel Institute of Pharmaceutical Education and Research, Shirpur, 425405 Dhule, Maharashtra, India. Electronic address: savitapat@gmail.com., Chaudhari H; Department of Pharmacy Practice, R. C. Patel Institute of Pharmaceutical Education and Research, Shirpur, 425405 Dhule, Maharashtra, India. Electronic address: hemakshi_c@yahoo.com., Patil C; Pain and Palliative Care, Kolhapur Cancer Centre, R S 238 Opp. Mayur Petrol Pump Gokul Shirgaon, 416234 Kolhapur, Maharashtra, India. Electronic address: docterchaitanya@gmail.com., Pawar R; Clinical Research Department, Kolhapur Cancer Centre, R S 238 Opp. Mayur Petrol Pump Gokul Shirgaon, 416234 Kolhapur, Maharashtra, India. Electronic address: edkolhapurcancercentre@gmail.com., Patil P; Clinical Research Department, Kolhapur Cancer Centre, R S 238 Opp. Mayur Petrol Pump Gokul Shirgaon, 416234 Kolhapur, Maharashtra, India. Electronic address: ppatil241997@gmail.com., More H; Counselling Department, Kolhapur Cancer Centre, R S 238 Opp. Mayur Petrol Pump Gokul Shirgaon, 416234 Kolhapur, Maharashtra, India. Electronic address: harshvardhanmore@gmail.com., Katolkar U; Pharmacology Department, R. C. Patel Institute of Pharmaceutical Education and Research, Shirpur, 425405 Dhule, Maharashtra, India. Electronic address: ujwal.katolkar@gmail.com.
Jazyk: angličtina
Zdroj: Journal of cancer policy [J Cancer Policy] 2024 Mar; Vol. 39, pp. 100460. Date of Electronic Publication: 2023 Dec 05.
DOI: 10.1016/j.jcpo.2023.100460
Abstrakt: In India the cancer burden for 2021 was 26.7 million disability-adjusted life years (DALYs), and this is expected to increase to 29.8 million in 2025 (Kulothungan et al., 2022). According to the World Health Organisation (WHO), cancer is a leading cause of death worldwide, accounting for one in six deaths. As per WHO, palliative care is a strategy that assists both adults and children along with their families in dealing with life-threatening illnesses. Currently, only 14% of those in need of pain and palliative (P&P) care receive it globally (WHO, 2020). Financial toxicity (FT) is the term used to describe the negative effects that an excessive financial burden resulting from cancer have on patients, their families, and society (Desai and Gyawali, 2020). Addressing this gap will require significant adjustments to both demand- and supply-side policies to ensure accessible and equitable cancer care in India (Caduff et al., 2019). Measuring FT along with health-related quality of life (HRQoL) represents a clinically relevant and patient-centred approach (de Souza et al., 2017).
Aim and Objective: To estimate FT and its association with quality of life (QoL).
Materials and Methods: This was an observational descriptive study conducted among cancer patients recommended for P&P care. Scores were estimated from September 2022 to February 2023 using official tools: the Functional Assessment for Chronic illness Treatment Compressive Score for Financial Toxicity (FACIT-COST) and the European Organisation for Research and Treatment of Cancer (EORTC) Quality of life Questionnaires for Cancer (QLQ30).
Results: From 150 patients (70 males and 80 females, mean age 54.96 ± 13.5 years), 92.6% suffered from FT. Eleven patients (7.3%) were under FT grade 0, 41 (27.3%) were FT grade 1, 98 (65.3%) were FT grade 2, and no patients were under FT grade 3. At criterial alpha 0.05 (95%CI), FT and the global score for HRQoL showed an association. Among inpatient department (IPD) expenses, medication bills contributed the greatest expense at 33%, and among outpatient department (OPD) expenses treatment expenses contributed 50% of the total. Breast cancer (30 cases, 20%) and oral cancer (26 cases, 17.3%) were the most frequent cancers.
Conclusion: FT measured using the COST tool showed an association with HRQoL.
Policy Summary: This paper refers to the insurance policies available for cancer patients irrespective of P&P care treatment.
Competing Interests: Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
(Copyright © 2023 Elsevier Ltd. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: